
University of Bath Researchers Propose 'THC Units' to Guide Safer Cannabis Consumption
Researchers at the University of Bath have proposed a 'THC unit' system to help consumers monitor cannabis potency and reduce the risk of Cannabis Use Disorder.
UK Cannabis News & Industry Insights
Cannabis Insider
Prescription cannabis, NHS developments, and patient access in the UK.

Researchers at the University of Bath have proposed a 'THC unit' system to help consumers monitor cannabis potency and reduce the risk of Cannabis Use Disorder.

A new study using UK Biobank data suggests that cannabis use among adults aged 40 to 77 is associated with larger brain volumes and improved cognitive performance, though researchers urge a nuanced interpretation.

A Somerset family spending £750 a month on private medical cannabis for their daughter’s epilepsy has met with a government health minister to push for wider NHS access.

Pharmacy giant Boots is set to launch its 'SureLeaf' service, becoming the first UK high street chemist to privately prescribe medicinal cannabis for chronic pain, insomnia, and anxiety.

A Birmingham chef struggling with PTSD and two decades of insomnia reports a life-changing recovery after accessing legal medical cannabis treatment.

A Birmingham chef suffering from PTSD and chronic sleep issues says his life has been transformed after accessing legal medical cannabis treatment.

A new archaeological study suggests humans were using psychoactive cannabis in Siberia 2,800 years ago, pushing back the timeline of documented consumption.

Jersey's health minister has announced plans to strengthen legislation for medicinal cannabis prescriptions following an inquest into a patient's death.

A new Nature Communications study shows how a cannabinoid can turn up a fear circuit in mice. It is not a study of joints, or of people — but it does give a mechanism for a feeling many users already know.

New NHS data reveals a significant shift in UK medical cannabis prescribing, with 85% of flower items now exceeding 22% THC potency.

Ananda Pharma has dosed the first patient in its Phase 2 ACTiON trial testing MRX1, a proprietary CBD medicine, for chemotherapy-induced peripheral neuropathy.

A US Phase 2 study presented in London found a purified THC and CBD oil sharply reduced agitation in hospice-eligible dementia patients — but researchers warn it is not the same as shop-bought cannabis products.

New Zealand producer Rua Bioscience has agreed to supply medical cannabis flower to one of the UK's largest private clinic and distribution groups, in a two-year deal worth more than NZ$10 million.

Research in The Journal of Physiology finds obese mice lost weight on both THC and whole-plant cannabis extract — but only the full extract improved blood sugar control, hinting that non-THC compounds may matter for metabolism.

Research in BMJ Mental Health using UK Biobank and US veteran data finds cannabis use in older adults is not associated with faster cognitive decline or higher dementia risk — though scientists warn heavy, long-term use remains poorly understood.

UK clinic Releaf has registered as a fully integrated GP practice, allowing it to prescribe standard BNF medicines for the significant share of patients who complete triage but are not eligible for medical cannabis.

Research published in the Journal of Workplace Behavioral Health links medical cannabis laws to a 6.9% drop in health-related absenteeism, with manual workers seeing the sharpest reductions.